Validation Study for Endometriosis PRO
Public ClinicalTrials.gov record NCT01643122. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Validation Study to Assess Psychometric Properties of a Newly Developed Patient Reported Outcome Tool for Endometriosis
Study identification
- NCT ID
- NCT01643122
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Bayer
- Industry
- Enrollment
- 275 participants
Conditions and interventions
Conditions
Interventions
- No drug Other
Other
Eligibility (public fields only)
- Age range
- 18 Years to 45 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2012
- Primary completion
- Jun 30, 2013
- Completion
- Aug 31, 2013
- Last update posted
- Oct 12, 2014
2012 – 2013
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Jonesboro | Arkansas | 72401 | — |
| Not listed | Sacramento | California | 95816 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | San Diego | California | 92108 | — |
| Not listed | San Francisco | California | 94102 | — |
| Not listed | New Haven | Connecticut | 06511 | — |
| Not listed | Decatur | Georgia | 30034 | — |
| Not listed | Champaign | Illinois | 61820 | — |
| Not listed | Worcester | Massachusetts | 01655 | — |
| Not listed | Rochester | Minnesota | 55905 | — |
| Not listed | Brooklyn | New York | 11203 | — |
| Not listed | Greensboro | North Carolina | 27408 | — |
| Not listed | Cincinnati | Ohio | 45242 | — |
| Not listed | Portland | Oregon | 97239 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | San Angelo | Texas | 76904 | — |
| Not listed | Salt Lake City | Utah | 84107 | — |
| Not listed | Sandy City | Utah | 84070 | — |
| Not listed | Norfolk | Virginia | 23502 | — |
| Not listed | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01643122, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 12, 2014 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01643122 live on ClinicalTrials.gov.